BASIC MECHANISMS OF SEIZURES

癫痫发作的基本机制

基本信息

项目摘要

This is a proposal to continue a very successful and highly productive program project entitled "Basic Mechanisms of Seizures". The overall goal of this program is to characterize structure-activity relationships, mechanisms and sites of action, and neurologic effects of alkyl- substituted butyrolactones and related compounds--a newly discovered class of neuroactive chemicals. Initial studies have demonstrated that these compounds can modulate the action of GABA, the major inhibitory neurotransmitter in mammalian CNS, by affecting its action at the GABA-A receptor-chloride ionophore. Several highly effective and widely used neurotropic drugs, particularly benzodiazepines and barbiturates, also act at the GABA-A receptor. This program tests the hypothesis that alkyl substituted butyrolactones have sites and mechanisms of action different from other compounds acting at the GABAA receptor-chloride ionophore and as a result of these distinct actions, these compounds have considerable potential for development as improved neurotropic therapeutic agents. The present program consists of three integrated component projects, a scientific (molecular biology) core and an administrative core. The major goals of the component projects are: 1 )To identify and synthesize new neuroactive alkyl-substituted butyrolactones and structurally related compounds and characterize their structure-activity relationships 2) To characterize the molecular sites and mechanisms of action and neurologic effects of alkyl-substituted butyrolactones and related compounds; and 3) To characterize the functional sites and mechanisms of action of alkyl- substituted butyrolactones and related compounds. These studies will utilize synthetic organic chemistry, neuropharmacology, electrophysiology, molecular biology and neuroanatomical methods and techniques. Our program brings together a group of experienced, talented and productive medical scientists who have special knowledge and research skills which make them particularly suited to carry out our goals. We have already demonstrated that we can work well together and can direct closely inter-related and complementary research projects. Our research should improve the understanding of the GABA-A receptor- chloride ionophore and other receptors in brain, help explain normal and abnormal GNS function and identify new drugs for the treatment of neurologic and psychiatric disorders including seizures and epilepsy.
这是一项非常成功和卓有成效的提案

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JAMES A FERRENDELLI其他文献

JAMES A FERRENDELLI的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JAMES A FERRENDELLI', 18)}}的其他基金

MOLECULAR & BEHAVIORAL NEUROPHARMACOLOGY OF BUTYROLACTONES & RELATED COMPOUNDS
分子
  • 批准号:
    6204991
  • 财政年份:
    1999
  • 资助金额:
    $ 84.86万
  • 项目类别:
MOLECULAR & BEHAVIORAL NEUROPHARMACOLOGY OF BUTYROLACTONES & RELATED COMPOUNDS
分子
  • 批准号:
    6112107
  • 财政年份:
    1998
  • 资助金额:
    $ 84.86万
  • 项目类别:
MOLECULAR & BEHAVIORAL NEUROPHARMACOLOGY OF BUTYROLACTONES & RELATED COMPOUNDS
分子
  • 批准号:
    6243469
  • 财政年份:
    1997
  • 资助金额:
    $ 84.86万
  • 项目类别:
BASIC MECHANISMS OF SEIZURES
癫痫发作的基本机制
  • 批准号:
    3107689
  • 财政年份:
    1979
  • 资助金额:
    $ 84.86万
  • 项目类别:
BASIC MECHANISMS OF SEIZURES
癫痫发作的基本机制
  • 批准号:
    3107693
  • 财政年份:
    1979
  • 资助金额:
    $ 84.86万
  • 项目类别:
BASIC MECHANISMS OF SEIZURES
癫痫发作的基本机制
  • 批准号:
    3107687
  • 财政年份:
    1979
  • 资助金额:
    $ 84.86万
  • 项目类别:
BASIC MECHANISMS OF SEIZURES
癫痫发作的基本机制
  • 批准号:
    3107688
  • 财政年份:
    1979
  • 资助金额:
    $ 84.86万
  • 项目类别:
BASIC MECHANISMS OF SEIZURES
癫痫发作的基本机制
  • 批准号:
    3107686
  • 财政年份:
    1979
  • 资助金额:
    $ 84.86万
  • 项目类别:
BASIC MECHANISMS OF SEIZURES
癫痫发作的基本机制
  • 批准号:
    3107692
  • 财政年份:
    1979
  • 资助金额:
    $ 84.86万
  • 项目类别:
BASIC MECHANISMS OF SEIZURES
癫痫发作的基本机制
  • 批准号:
    2262694
  • 财政年份:
    1979
  • 资助金额:
    $ 84.86万
  • 项目类别:

相似海外基金

Novel pediatric anticonvulsants for nerve agents
用于神经毒剂的新型儿科抗惊厥药
  • 批准号:
    10004277
  • 财政年份:
    2020
  • 资助金额:
    $ 84.86万
  • 项目类别:
Novel pediatric anticonvulsants for nerve agents
用于神经毒剂的新型儿科抗惊厥药
  • 批准号:
    10475298
  • 财政年份:
    2020
  • 资助金额:
    $ 84.86万
  • 项目类别:
Novel pediatric anticonvulsants for nerve agents
用于神经毒剂的新型儿科抗惊厥药
  • 批准号:
    10693904
  • 财政年份:
    2020
  • 资助金额:
    $ 84.86万
  • 项目类别:
Novel Water-Soluble Adjunct Anticonvulsants for Nerve Agents
用于神经毒剂的新型水溶性辅助抗惊厥药
  • 批准号:
    10013749
  • 财政年份:
    2020
  • 资助金额:
    $ 84.86万
  • 项目类别:
Study on how anticonvulsants affect car driving
抗惊厥药如何影响汽车驾驶的研究
  • 批准号:
    20K17977
  • 财政年份:
    2020
  • 资助金额:
    $ 84.86万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Novel Water-Soluble Adjunct Anticonvulsants for Nerve Agents
用于神经毒剂的新型水溶性辅助抗惊厥药
  • 批准号:
    10266034
  • 财政年份:
    2020
  • 资助金额:
    $ 84.86万
  • 项目类别:
Novel Water-Soluble Adjunct Anticonvulsants for Nerve Agents
用于神经毒剂的新型水溶性辅助抗惊厥药
  • 批准号:
    10475109
  • 财政年份:
    2020
  • 资助金额:
    $ 84.86万
  • 项目类别:
Novel pediatric anticonvulsants for nerve agents
用于神经毒剂的新型儿科抗惊厥药
  • 批准号:
    10248384
  • 财政年份:
    2020
  • 资助金额:
    $ 84.86万
  • 项目类别:
Prevention of neuropathic pain by antidepressants and anticonvulsants: in vivo patch-clamp analysis
抗抑郁药和抗惊厥药预防神经性疼痛:体内膜片钳分析
  • 批准号:
    24592355
  • 财政年份:
    2012
  • 资助金额:
    $ 84.86万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Anticonvulsants, ischemic seizures and regeneration in the immature brain
抗惊厥药、缺血性癫痫发作和未成熟大脑的再生
  • 批准号:
    8492175
  • 财政年份:
    2009
  • 资助金额:
    $ 84.86万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了